Hjem › Ikke-småcellet lungekreft › California › Torrance
Kliniske studier for Ikke-småcellet lungekreft i Torrance, CA
11 studier for Ikke-småcellet lungekreft søker deltakere på steder i og rundt Torrance (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
RekruttererFase 3
- Torrance Memorial Physician Network - Cancer Care, Torrance
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RekruttererFase 3
- Torrance Memorial Physician Network - Cancer Care, Torrance
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekruttererFase 3
- Cancer and Blood Specialty Clinic, Torrance
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
RekruttererObservasjonsstudie
- Torrance Memorial Physician Network-Cancer Care, Torrance
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
RekruttererFase 3
- Clinical Study Site, Torrance
Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer
RekruttererFase 1
- Cedars-Sinai Cancer at Hunt Cancer Center - TMPNCC, Torrance
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RekruttererFase 1
- Cancer AND Blood Specialty Clinic, Torrance
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruttererFase 2
- Torrance Memorial Physician Network - Cancer Care, Torrance
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2/3
- City of Hope South Bay, Torrance
- Torrance Memorial Physician Network - Cancer Care, Torrance
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2
- Torrance Memorial Physician Network - Cancer Care, Torrance
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
RekruttererFase 2
- City of Hope South Bay, Torrance
Ikke-småcellet lungekreft-studier i andre byer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andre studier i Torrance
- Brystkreft9 studier
- Overvekt9 studier
- Fedme9 studier
- Lungekreft7 studier
- Kardiovaskulær sykdom7 studier
- Blærekreft7 studier
- Schizofreni6 studier
- Hjertesvikt5 studier
- Aterosklerose5 studier
- Metastatisk kreft4 studier
- Kolorektal kreft4 studier
- Koronararteriesykdom4 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.